BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Pharmagene Laboratories Limited 

2 Orchard Road

Royston  Hertfordshire  SG8 5HD  United Kingdom
Phone: 44-0-1763-211600 Fax: 44-0-1763-211555


SEARCH JOBS
Pharmagene is a drug discovery company whose aim is to provide better drug discovery based on the use of human biological information.

Throughout the drug discovery process, key scientific and financial decisions have to be made which impact on your level of future success. It is therefore vital to have the most comprehensive and appropriate information available to enable you to make the right decisions.

Utilising our combination of human tissue, appropriate technologies, intellectual strength and experience, Pharmagene can generate the information needed to address many of the key questions faced during drug discovery including:

  • How to evaluate which targets are relevant to human disease?
  • How to increase the probability of success with candidate compounds in the clinic?
  • How to extract greater value from existing compounds?


Pharmagene generates value in two ways.

First, we work in partnership with pharmaceutical and biotechnology companies to provide the information that is needed to support their drug discovery activities.

Our strong product offering, designed to span the entire drug discovery process and based on our combination of human tissue, appropriate technologies, intellectual strength and experience.

  • Pharmagene TargetEvaluator™ is a comprehensive human gene expression database providing information on the expression of gene transcripts in a vast array of diseased and non-diseased human tissues.

  • Pharmagene Phase ZERO™ combines our unrivalled access to human tissue and broad suite of technologies to build more confidence in the process of lead identification and optimisation, enabling you to rigorously profile your drug candidates in human tissues prior to committing to Phase I clinical trials.

  • Pharmagene Indication Switch™ is a combined approach where by we evaluate your existing compounds using all of our available technologies to reveal previously unknown therapeutic indications.


Secondly we utilise this approach to actively pursue an increasing number of internal drug discovery programmes.

Pharmagene has a range of advanced programs on validated targets. The most advanced program, PGN0052 (for cystic fibrosis), was identified using Pharmagene Indication Switch™ technology and is now on the path to clinical development. In addition, Pharmagene's pipeline includes a range of programs at the target validation stage as well as a significant basic research effort.

Last Updated: 06-11-02


 Key Statistics


Email: info@pharmagene.com
Ownership: Public

Web Site: Pharmagene Laboratories Limited
Employees: 100
Symbol: PGN.L
 









 Company News
Pharmagene In Reverse Takeover Of US Firm Asterand, Inc. 10/19/2005 5:12:12 PM    More...
Enzon (ENZN) And Pharmagene Announce Agreement To Develop PEGylated Secretin For Cystic Fibrosis 10/19/2005 5:11:24 PM    More...
Pharmagene PLC Announces Clinical Trial Results Of PGN1164 10/19/2005 5:10:41 PM    More...
Deal With Bristol-Myers Squibb Company (BMY) Boosts Pharmagene 10/19/2005 5:09:35 PM    More...

//-->